Jamil Khurram (CIK 2032345) reported 30 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-16). Recent activity: Buy GALT (16,250 shares), Sell GALT (16,250 shares), Buy GALT (2,533 shares), Sell GALT (2,037 shares), Buy GALT (2,037 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 16,250 | $49,400 |
| 2026-07-16 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 16,250 | $83,284 |
| 2026-06-30 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 2,533 | $6,332 |
| 2026-06-30 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 2,037 | $10,185 |
| 2026-06-30 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 2,037 | $4,481 |
| 2026-06-30 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 2,533 | $12,665 |
| 2026-06-30 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 47,467 | $118,668 |
| 2026-06-30 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 47,467 | $239,234 |
| 2026-06-25 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 7,557 | $9,295 |
| 2026-06-25 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 7,557 | $23,729 |
| 2026-05-28 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 568 | $699 |
| 2026-05-28 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 568 | $1,761 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 13,055 | $54,831 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 25,499 | $99,446 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 21,446 | $78,278 |
| 2026-01-06 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 60,000 | $0 |
| 2026-01-05 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 8,125 | $9,994 |
| 2026-01-05 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 8,125 | $33,069 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 4,479 | $31,532 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 6,463 | $14,219 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 6,463 | $45,500 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 8,500 | $21,250 |
| 2025-12-19 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 8,500 | $59,840 |
| 2025-11-14 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Buy | 41,500 | $91,300 |
| 2025-11-14 | GALECTIN THERAPEUTICS INC (GALT) | Chief Medical Officer | Sell | 21,867 | $119,612 |
Source: SEC Form 4 filings · as of 2026-07-16